IKT - Inhibikase Therapeutics, Inc.
2.19
0.190 8.676%
Share volume: 161,439
Last Updated: 05-12-2025
Pharmaceutical Products/Biological Products, Except Diagnostic Substances:
0.01%
PREVIOUS CLOSE
CHG
CHG%
$2.00
0.19
0.10%
Summary score
35%
Profitability
43%
Dept financing
11%
Liquidity
48%
Performance
30%
Sector
Manufacturing
Industry
Pharmaceutical Products/Biological Products, Except Diagnostic Substances
Long-term ratios 31-Dec-2020 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.46%
Return on assets
-28.51%
Return on sales
-36732160.16%
Return on invested capital
149.76%
Total debt ratio
22.8%
Debt ratio change over timeo
-0.9%
Current Ratio
9.32%
Quick Ratio
9.75%
Cash Position Ratio
7.99%
Short-term ratios 31-Dec-2023 - 31-Dec-2024
The data are presented for the financials results of the quarters of the last year.
Return on equity
0%
Return on assets
-61.67%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
49.24%
Debt ratio change over timeo
-0.71%
Current Ratio
8.02%
Quick Ratio
0%
Cash Position Ratio
4.18%
Last quarter ratios 31-Dec-2024
The data are presented for the financials results of the last quarter.
Return on equity
0%
Return on assets
-13.11%
Return on sales
0%
Return on invested capital
0%
Total debt ratio
3.79%
Debt ratio change over time
0%
Current Ratio
26.37%
Quick Ratio
0%
Cash Position Ratio
15.13%
Performance ratios (change over 4 years) 31-Dec-2020 - 31-Dec-2024
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-112.5%
Return on assets
-112.85%
Return on sales
-21038890.1%
Return on invested capital
11.64%
Total debt ratio
-89.97%
Debt ratio change over time
-0.9%
Current Ratio
7.18%
Quick Ratio
7.75%
Cash Position Ratio
6.68%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | IKT | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | -20.46% | 18.63% | 6.54% | 16.49% |
| Return on assets | -28.51% | 3.07% | 3.1% | 15.3% |
| Return on sales | -36732160.16% | 30.43% | 28.58% | 7.81% |
| Return on invested capital | 149.76% | 5.33% | 3.53% | -56.8% |
| Profitability | 25% | 56% | 38% | 54% |
| Total debt ratio | 22.8% | 92.23% | 67.28% | 20.78% |
| Debt ratio change over time | -0.9% | 20.48% | 134.64% | -1.07% |
| Dept financing | 6% | 29% | 43% | 6% |
| Current Ratio | 8.02% | 1.32% | 1.27% | 11.38% |
| Quick Ratio | 0% | 0.95% | 1.11% | 11.16% |
| Cash Position Ratio | 4.18% | 0.47% | 0.47% | 5.59% |
| Liquididy | 75% | 11% | 8% | 48% |
| Short-term ratios | IKT | AMGN | GILD | BNTX |
|---|---|---|---|---|
| Return on equity | 0% | 0% | 0% | -1.58% |
| Return on assets | -61.67% | 2.13% | 0.76% | -2.3% |
| Return on sales | 0% | 21.39% | 4.39% | -272.71% |
| Return on invested capital | 0% | 0% | 0% | -13.26% |
| Profitability | 50% | 50% | 14% | 0% |
| Total debt ratio | 49.24% | 93.35% | 67.02% | 10.28% |
| Debt ratio change over time | -0.71% | 0% | 15.75% | -0.69% |
| Dept financing | 13% | 25% | 43% | 3% |
| Current Ratio | 8.02% | 1.32% | 1.27% | 11.38% |
| Quick Ratio | 0% | 0.95% | 1.11% | 11.16% |
| Cash Position Ratio | 4.18% | 0.47% | 0.47% | 5.59% |
| Liquididy | 36% | 7% | 7% | 75% |
